Verint Systems Inc. Apr 11

  • ID: 1712051
  • April 2011
  • Standard & Poors
1 of 3

Diversified portfolio of products and services, as well as geographic end markets; and Solid and growing recurring revenue base. Concerns regarding majority owner's strategies and financial position; Highly competitive and fragmented end markets with larger and better capitalized competitors; and Acquisitive growth strategy. Standard & Poor's Ratings Services' ratings on Melville, N.Y.-based Verint Systems Inc. reflect the highly competitive nature of the software industry, its reliance on specialized product offerings, and an aggressive financial profile, characterized by a fairly acquisitive growth strategy and elevated leverage. The rating also incorporates concerns that the company's majority owner, Comverse Technology Inc., which is experiencing ongoing legal, accounting, and operational issues, controls four of the eight board seats. Favorable market growth--particularly through the recession,...

Companies mentioned in this report are:
- Verint Systems Inc.

Action: Review

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

- Verint Systems Inc.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our


Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.